Some individuals naturally have variations in these receptors that may enhance or diminish the medication's effects, though genetic testing for tirzepatide response is not currently part of routine clinical practice
Additionally, the FDA label for tirzepatide (Mounjaro, Zepbound) specifically warns that it may decrease the absorption of oral contraceptives, recommending backup contraception during initiation and dose escalation
#ConceptLifeSciences #Webinar #DrugDiscovery #Inflammasome #Neuroscience #Biotech #Pharma #InVitro #ScientificInnovation #TranslationalScience To view or add a comment, sign in People often ask what my day-to-day role involves and a significant part of it is bringing webinars to life
Few compounders offer a 1.125mg starting dose or eight different vial types optimized for each dose level
There are no easy answers
Patients should be empowered as active participants in treatment decisions, with ongoing dialogue about benefits, risks, and treatment goals tailored to their individual circumstances
